Tirosint: payments to doctors
Payments that named Tirosint as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.5M
- Providers
- 17,136
- Transactions
- 61,155
- Average per transaction
- $24
The per-transaction average — $24 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 17,136 providers the average total is $85, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| IBSA Pharma Inc. | $1,422,013 | 97.6% |
| IBSA Institut Biochimique SA | $35,219 | 2.4% |